Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01539759 · ClinicalTrials.gov registry record · NA

Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial

A NA study of Cesarean Section and Intrauterine Devices, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT01539759 is a NA study of Cesarean Section and Intrauterine Devices that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 112 participants, below the 162-participant average among 14 other Cesarean Section trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01539759, a NA study of Cesarean Section and Intrauterine Devices, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. After randomization, subjects will be given a choice of the Mirena® IUD or the Paragard® IUD. Data collection will occur at baseline, delivery, the 4-8 week postpartum visit, and 2 follow-up encounters at 3 and 6 months. We hypothesize that women who receive an IUD at the time of cesarean will be more likely to use an IUD 6 months later than women who plan on receiving an IUD 4-8 weeks after delivery.

Interventions

  • DEVICE Immediate Postplacental Placement of an IUD during cesarean delivery

Study Locations (1)

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2012-03
Est. Completion 2014-08
Phase NA

What the Registry Record Tells You About NCT01539759

The ClinicalTrials.gov registry entry for NCT01539759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 14 other Cesarean Section trials with a reported enrollment target (31% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cesarean Section appearing as the primary indexed condition, and to 1 intervention - of which Immediate Postplacental Placement of an IUD during cesarean delivery is the first listed.

NCT01539759 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01539759 about?

NCT01539759 is a clinical study titled "Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial". This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. ...

What is the current status of trial NCT01539759?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-03. Estimated completion is 2014-08.

What conditions does trial NCT01539759 study?

This clinical trial studies the following conditions: Cesarean Section, Intrauterine Devices.

What interventions are being tested in trial NCT01539759?

The interventions under investigation include: Immediate Postplacental Placement of an IUD during cesarean delivery (DEVICE).

Who is sponsoring clinical trial NCT01539759?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01539759 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cesarean Section

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.